Nido Surgical seeks $1.5m for next-gen cardiac surgery tools

del Nido Stealthy Nido Surgical took the 1st steps toward raising a hoped-for $1.5 million, pulling in $105,000 from 3 unnamed investors in a debt-and-options round, according to a regulatory filing. Nido Surgical, named for co-founder and cardiac surgery chief at Boston Children’s Hospital Dr. Pedro del Nido, is developing minimally invasive instruments for image-guided, beating-heart surgery, according to the LinkedIn profile of co-founder, president &CEO Gerald Moore. The company was formed to commercialize technology created by del Nido and his team at Children’s over the past 10 years, according to Moore’s profile. Nido Surgical’s SEC filing also lists as a manager Boston Children’s Dr. Nikolay Vasilyev, a cardiac surgery researcher focused on instruments and device design for valve interventions and septal defects closure, new imaging techniques, computer modeling and simulation, according to the hospital’s website. The post Nido Surgical seeks $1.5m for next-gen cardiac surgery tools appeared first on MassDevice.
Source: Mass Device - Category: Medical Equipment Authors: Tags: Cardiovascular Funding Roundup Surgical Nido Surgical Source Type: news

Related Links:

CONCLUSION: Despite the limitation due to the limited number of patients studied, we believe that future studies conducted with larger patient groups would further support our findings. KEY WORDS: Minimally invasive cardiac surgery, Pain, Mini thoracotomy, mini sternotomy, VAS Score. PMID: 30394365 [PubMed - as supplied by publisher]
Source: Annali Italiani di Chirurgia - Category: Surgery Tags: Ann Ital Chir Source Type: research
In this study, we compared creatine kinase MB (CK-MB), H-FABP, and cardiac troponin T (cTnT) after coronary artery bypass grafting (CABG), heart valve surgery, or septal defect surgery to evaluate the difference in detecting myocardial injury between three markers.MethodsA total of 69 patients (CABG, 32; valve surgery, 27; and septal defect surgery, 10) were prospectively enrolled. Blood samples were taken at specific intervals.ResultsMean amount (AUC0-72h) of CK-MB and cTnT released for 72 h in the patients with valve surgery were 2446 h·ng/ml and 93.2 h·ng/ml, which were significantly larger than thos...
Source: Clinica Chimica Acta - Category: Laboratory Medicine Source Type: research
In this study, we compared creatine kinase MB (CK-MB), H-FABP, and cardiac troponin T (cTnT) after coronary artery bypass grafting (CABG), heart valve surgery, or septal defect surgery to evaluate the difference in detecting myocardial injury between three markers. METHODS: A total of 69 patients (CABG, 32; valve surgery, 27; and septal defect surgery, 10) were prospectively enrolled. Blood samples were taken at specific intervals. RESULTS: Mean amount (AUC0-72h) of CK-MB and cTnT released for 72 h in the patients with valve surgery were 2446 h·ng/ml and 93.2 h·ng/ml, which were significantly ...
Source: International Journal of Clinical Chemistry - Category: Chemistry Authors: Tags: Clin Chim Acta Source Type: research
Conclusion: There is a change in the spectrum and antimicrobial susceptibility of organisms causing IE. We encountered several difficulties with the use of the MDC as 43.5% patients had no predisposing factors for IE and blood cultures were negative in 22.6% cases. In our study, PVE was the most common predisposing condition for IE. VGS followed by enterococci were found to be the commonest cause for IE in our setting. Both organisms show variable drug resist patterns. MRSA was isolated in 1 patient only. Thus vancomycin may not be required as empiric treatment in our setting. This is important from the perspective of anti...
Source: Journal of the Association of Physicians of India - Category: General Medicine Tags: J Assoc Physicians India Source Type: research
Publication date: Available online 13 October 2018Source: Cor et VasaAuthor(s): Tomáš Toporcer, Karol Trejbal, Martin Ledecký, Martin Sivčo, Adrián Kolesár, František SabolAbstractVentricular septal defect (VSD) is a rare complication of surgical aortic valve replacement (AVR) and transcatheter aortic valve replacement (TAVI), with an incidence of 1%.An 81-year-old man underwent AVR with double aortocoronary bypass. Several hours after surgery haemodynamic instability accrued, and echocardiography showed a VSD. The patient underwent another surgery with the use of cardiopulmonary ...
Source: Cor et Vasa - Category: Cardiology Source Type: research
ConclusionsIntraoperative device closure of a pmVSD via the right-thoracic-minimal-incision-to-right-ventricle approach is safe and effective. This procedure can avoid some of the shortcomings caused by sternotomy, uses an incision with an improved cosmetic appearance, and is worth recommendation.
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research
CONCLUSIONS: Intraoperative device closure of a pmVSD via the right-thoracic-minimal-incision-to-right-ventricle approach is safe and effective. This procedure can avoid some of the shortcomings caused by sternotomy, uses an incision with an improved cosmetic appearance, and is worth recommendation. PMID: 30312613 [PubMed - as supplied by publisher]
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Ann Thorac Surg Source Type: research
ConclusionThe Nit-Occlud”-Lê VSD coil device with high safety level used for selected cases of VSDs. The device has minimal effects on the aortic and tricuspid valve, and there was no permanent AV block especially in patients with PM VSDs. Patients with a residual shunt should be followed, especially for the hemolysis.
Source: Journal of the Saudi Heart Association - Category: Cardiology Source Type: research
Publication date: Available online 4 October 2018Source: The Annals of Thoracic SurgeryAuthor(s): Carlos M. Mery, Rodrigo Zea-Vera, Martin A. Chacon-Portillo, Huirong Zhu, William B. Kyle, Iki Adachi, Jeffrey S. Heinle, Charles D. FraserBackgroundContemporary outcomes of complete atrioventricular septal defect (CAVSD) repair, particularly for defects with associated abnormalities, is unclear. The goal of this study is to report an all-inclusive experience of CAVSD repair using a consistent surgical approach.MethodsAll patients undergoing CAVSD repair between 1995 and 2016 at our institution were included. Patients were div...
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research
CONCLUSIONS: MIMVS is a feasible, safe, and reproducible approach with low mortality and morbidity. Mitral valve surgery through a small thoracotomy is a good alternative to conventional surgical access. PMID: 30232298 [PubMed - as supplied by publisher]
Source: Annals of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Ann Thorac Cardiovasc Surg Source Type: research
More News: Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Children | Computers | Funding | Heart | Heart Valve Surgery | Hole in the Heart | Hospital Management | Hospitals | Medical Devices | Websites